Skip to Content

Parecoxib Approval Status

  • FDA approved: No
  • Generic name: Parecoxib
  • Company: Pfizer Inc.
  • Treatment for: Pain

Parecoxib sodium is a non-narcotic injectable COX-2 selective analgesic for the treatment of acute pain.

In September 2005, Pfizer Inc. announced the receipt of a Complete Response Letter from the U.S. Food and Drug Administration (FDA), advising the company that the New Drug Application (NDA) for parecoxib had not been approved.

Development Status and FDA Approval Process for Parecoxib

Sep 20, 2005Pfizer Receives FDA Non-Approvable Letter on Parecoxib

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.